FREQUENCY OF JANUS ASSOCIATED KINASE 2 (JAK2) MUTATION IN PATIENTS OF BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

JAK2 Mutation

Authors

  • Maj Muhammad Arif Sadiq Haematology Department AFIP Rawalpindi
  • Suhaib Ahmed . Armed Forces Institute of Pathology Rawalpindi
  • Nadir Ali . Armed Forces Institute of Pathology Rawalpindi

Keywords:

Polycythemia vera, Essential thrombocythemia, Idiopathic myelofibrosis, myeloproliferative neoplasm, JAK2 mutation

Abstract

Objective: To determine the frequency of Janus associated kinase 2 mutation in the patients of BCR-ABL negative classical myeloproliferative neoplasms.
Study Design: Cross-sectional descriptive study
Place and Duration of Study: Molecular Department of Haematology, Armed Forces Institute of Pathology (AFIP), Rawalpindi from Jul 2011 to Jul 2012.
Patients and Methods: Ninety three consecutive patients of Polycythaemia vera (PV), Essential thrombocythaemia (ET) and Idiopathic myelofibrosis (IMF) diagnosed by the conventional haematological criteria were included in the study. All patients were screened for G-T point mutation (V617F) in the JAK2 gene on chromosome 9 by an allele specific PCR.
Results: Out of the 93 myeloproliferative neoplasm (MPN) patients, 33(35%) had polycythaemia vera, 36(39%) had essential thrombocythaemia and 24(26%) had idiopathic myelofibrosis. JAK2 mutation was seen in 64/93 (69%) patients including 33/33(100%) in PV, 19/36(52.6%) in ET and 12/24(50%) in IMF.
Conclusion: Classical myeloproliferative neoplasms are an important group of heamatological disorder in our country. JAK2 gene mutation is seen in significant proportion of these disorders (69%). JAK2 mutation analysis can be used to differentiate between polycythemia vera and secondary polycythemia in most cases with near certainty, where it was found in 100% of the cases.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

30-06-2013

How to Cite

Sadiq, M. M. A., ., S. A., & ., N. A. (2013). FREQUENCY OF JANUS ASSOCIATED KINASE 2 (JAK2) MUTATION IN PATIENTS OF BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: JAK2 Mutation. Pakistan Armed Forces Medical Journal, 63(2), 235–240. Retrieved from https://pafmj.org/PAFMJ/article/view/2257

Issue

Section

Original Articles

Most read articles by the same author(s)